RT Journal Article
SR Electronic
T1 Impact of diabetes mellitus and co-morbidities on mortality in patients with COVID-19
JF Saudi Medical Journal
JO Saudi Med J
FD Prince Sultan Military Medical City
SP 67
OP 73
DO 10.15537/smj.2023.44.1.20220462
VO 44
IS 1
A1 Sindi, Anees A.
A1 Tashkandi, Wail A.
A1 Jastaniah, Mohammed W.
A1 Bashanfar, Mohammed A.
A1 Fakhri, Ahmed F.
A1 Alsallum, Fahad S.
A1 Alguydi, Hamdan B.
A1 Elhazmi, Alyaa
A1 Al-Khatib, Talal A.
A1 Alawi, Maha M.
A1 Abushoshah, Ibrahim
YR 2023
UL http://smj.org.sa/content/44/1/67.abstract
AB Objectives: To describe the effect of diabetes mellitus (DM) on clinical outcomes of patients admitted with COVID-19 infection.Methods: We carried out a single center, observational, retrospective study. We included adult patients with laboratory-confirmed diagnosis of COVID-19 admitted to a tertiary hospital in Jeddah, Saudi Arabia, from April 2020 to December 2020. Electronic medical records were reviewed for demographics, clinical status, hospital course, and outcome; and they were compared between the patients with or without DM.Results: Out of 198 patients included in the study, 86 (43.4%) were diabetic and 112 (56.5%) were non-diabetic. Majority of the patients were males 139 (70.2%) with a mean age of 54.14±14.89 years. In-hospital mortality rate was higher in diabetic patients than in non-diabetic patients (40 vs. 32; p=0.011). The most common comorbidity was hypertension (n=95, 48%) followed by ischemic heart disease (n=35, 17.7%), chronic kidney disease (n=17, 9.6%), and bronchial asthma (n=10, 5.1%).Conclusion: The risk of SARS-CoV-2 infection is higher among diabetic patients; particularly, those with preexisting co-morbidities or geriatric patients. Diabetic patients are prone to a severe clinical course of COVID-19 and a significantly higher mortality rate.